Indian Government Proposes New Entry Points for Importing Medicines and Medical Devices

New Delhi, November 3 (Daily Kiran) : The Indian government is taking significant steps to simplify the import process for medicines, medical devices, and cosmetics. On November 3, the Ministry of Health and Family Welfare proposed an amendment to Rule 43A of the Drugs Rules, 1945. This amendment aims to expand the network of authorized entry points for imports, thereby strengthening the supply chain for healthcare products.

According to the notification issued on November 3, Rule 43A of the Drugs Rules, 1945 specifies the authorized ports, airports, railway stations, and other entry points through which medicines can be imported into India.

To facilitate trade and enhance the efficiency of import procedures, the ministry has proposed adding several new locations to the list of authorized points. These include additional Inland Container Depots (ICDs), a Special Economic Zone (SEZ), and an international airport.

Proposed new locations encompass ICD Sonipat, Piyala, and Harsaru in Haryana; ICD Dadri in Uttar Pradesh; ICD Gandhinagar/Mundra in Gujarat; ICD Sanath Nagar and Thimmapur in Hyderabad, Telangana; ICD Whitefield in Bengaluru, Karnataka; SEZ Bommasandra in Karnataka; and the Noida International Airport in Uttar Pradesh for air imports of medicines.

These new locations will be integrated into the existing network of authorized import gateways, which includes the ICDs at Dhanad and Tihi in Indore, Madhya Pradesh, along with previously notified airports for medicine imports.

The ministry believes that this proposed expansion will assist importers in clearing shipments closer to their manufacturing units, warehouses, and distribution centers. This will reduce internal transportation distances, lower logistics costs, and minimize delays in the movement of imported shipments. Additionally, it aims to enhance operational convenience for importers and facilitate more efficient movement of medicines, medical devices, and cosmetics across various regions of the country.

Through this proposed amendment, the ministry seeks to strengthen the supporting infrastructure for importing healthcare products, promote ease of doing business, and contribute to a more efficient and responsive supply chain, ensuring timely availability of essential healthcare products.

Stakeholders are encouraged to submit any objections or suggestions regarding the proposed amendment to the Under Secretary (Drug Regulation) at the Ministry of Health and Family Welfare or via email. The draft notification is available on the official gazette link.